Here's a start..."Hard to Treat Diseases Incorporated (HTDS) has announced that consultants of the Company are meeting with a P-3 manufacturer and an FDA testing group this week. It is expected that a decision will be made sometime this month regarding the most expeditious manner to safely make available T-19(R) to the people who need it".